SB 518 Oklahoma Senate · 2026 Regular Session

Medical marijuana packaging; requiring certain warnings on labels. Effective date.

SB 518 requires medical marijuana businesses in Oklahoma to use specific warning labels on all products sold to licensed patients. The labels must include mandatory statements like "For use by licensed medical marijuana patients only," "Keep out of reach of children," and warnings about driving under influence and pregnancy risks, along with potency details (THC/cannabinoids) and contaminant testing information. The law prohibits child-targeted packaging (such as cartoon characters) and bans health benefit claims on product containers. It applies to all medical marijuana businesses and takes effect November 1, 2025, after becoming law without the governor's signature on May 21, 2025.
Bill status signed all 5 stages cleared
Introduction
Feb 2025
Committee Review
May 2025
Senate Passage
May 2025
House Passage
Apr 2025
Signed into Law
May 2025
Introduced Feb 3, 2025 Signed May 21, 2025
Maddy AI version diff · 7 comparisons

What changed between versions

Floor (House) Floor (Senate) · 2 edits
MINOR
The bill was moved from the House version to the Senate floor version, resulting in minor formatting updates and a single substantive change to the warning labels required on medical marijuana packaging. The House version required a warning about birth defects for pregnant women, while the Senate version removed this specific warning, leaving only warnings about patient-only use, keeping products away from children, and the dangers of driving under the influence.
REQUIREMENT

The specific warning text on medical marijuana labels was changed to remove the requirement for a statement warning women about birth defects during pregnancy.

TECHNICAL

The bill header was updated from 'House of Representatives' to 'Senate Floor Version,' and the committee report section was updated to reflect the Senate Committee on Business and Insurance instead of the House Committee on Health and Human Services Oversight.

Floor votes · Senate Mar 27, 2025 · House Apr 29, 2025

How they voted

377
Passed · 5 other
Total votes 49
Mar 27, 2025
D Democratic9
5 Yea 4 Nay
55% Yea
R Republican40
32 Yea 3 Nay 5
80% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
27
Key actions
9
Committee
7
May 13, 2025
Committee
Referred for enrollment
upper
May 13, 2025
Upper · Passed
Measure passed: Ayes: 38 Nays: 6
upper
May 13, 2025
Upper · Passed
HAs adopted
upper
Apr 30, 2025
Lower · Passed
Engrossed, signed, to Senate
lower
Apr 29, 2025
Committee
Referred for engrossment
lower
Apr 29, 2025
Lower · Passed
Third Reading, Measure passed: Ayes: 81 Nays: 2
lower
Apr 16, 2025
Lower · Passed
CR; Do Pass, amended by committee substitute Health and Human Services Oversight Committee
lower
Apr 10, 2025
Lower · Passed
Policy recommendation to the Health and Human Services Oversight committee; Do Pass, amended by committee substitute Alcohol, Tobacco and Controlled Substances
lower
Apr 1, 2025
Committee
Referred to Alcohol, Tobacco and Controlled Substances
lower
Mar 31, 2025
Introduced
First Reading
lower
Mar 31, 2025
Upper · Passed
Engrossed to House
upper
Mar 27, 2025
Committee
Referred for engrossment
upper
Mar 27, 2025
Upper · Passed
Measure passed: Ayes: 36 Nays: 7
upper
Feb 13, 2025
Upper · Passed
Reported Do Pass Business and Insurance committee; CR filed
upper
Feb 3, 2025
Introduced
First Reading
upper
2 primary · 0 co-sponsors

Sponsors